Dirk‐Jan Reijngoud

13.1k total citations · 3 hit papers
159 papers, 10.0k citations indexed

About

Dirk‐Jan Reijngoud is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Dirk‐Jan Reijngoud has authored 159 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 69 papers in Clinical Biochemistry and 54 papers in Physiology. Recurrent topics in Dirk‐Jan Reijngoud's work include Metabolism and Genetic Disorders (69 papers), Diet and metabolism studies (34 papers) and Metabolism, Diabetes, and Cancer (18 papers). Dirk‐Jan Reijngoud is often cited by papers focused on Metabolism and Genetic Disorders (69 papers), Diet and metabolism studies (34 papers) and Metabolism, Diabetes, and Cancer (18 papers). Dirk‐Jan Reijngoud collaborates with scholars based in Netherlands, United States and France. Dirk‐Jan Reijngoud's co-authors include Albert K. Groen, Barbara M. Bakker, Karen van Eunen, Gijs den Besten, Koen Venema, Theo H. van Dijk, J. M. Tager, Rick Havinga, Albert Gerding and Folkert Kuipers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Dirk‐Jan Reijngoud

156 papers receiving 9.8k citations

Hit Papers

The role of short-chain f... 2013 2026 2017 2021 2013 2015 2013 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk‐Jan Reijngoud Netherlands 45 5.9k 3.6k 1.5k 1.2k 1.2k 159 10.0k
Puttur D. Prasad United States 73 8.4k 1.4× 2.0k 0.6× 1.8k 1.2× 660 0.6× 1.3k 1.1× 172 15.8k
Rolf K. Berge Norway 60 6.4k 1.1× 3.4k 0.9× 1.5k 1.0× 1.8k 1.5× 2.4k 2.1× 369 12.3k
Hannelore Daniel Germany 58 5.6k 0.9× 2.2k 0.6× 484 0.3× 930 0.8× 1.9k 1.6× 232 11.9k
Mohammad Bohlooly‐Y Sweden 33 6.1k 1.0× 2.7k 0.7× 564 0.4× 1.2k 1.0× 882 0.8× 80 9.6k
James R. Bain United States 59 8.9k 1.5× 6.9k 1.9× 858 0.6× 2.7k 2.3× 974 0.8× 211 16.9k
Hooman Allayee United States 50 5.5k 0.9× 3.7k 1.0× 421 0.3× 1.7k 1.4× 930 0.8× 150 12.0k
Philip Newsholme Australia 66 5.6k 0.9× 4.6k 1.3× 760 0.5× 1.4k 1.2× 2.4k 2.0× 241 15.7k
Sidney M. Morris United States 57 4.2k 0.7× 4.6k 1.3× 1.0k 0.7× 791 0.7× 831 0.7× 131 13.5k
Gerhard Liebisch Germany 66 9.9k 1.7× 2.5k 0.7× 404 0.3× 1.9k 1.6× 1.2k 1.0× 302 16.3k
Sean H. Adams United States 42 4.5k 0.8× 4.3k 1.2× 662 0.4× 1.6k 1.4× 1.1k 0.9× 162 9.0k

Countries citing papers authored by Dirk‐Jan Reijngoud

Since Specialization
Citations

This map shows the geographic impact of Dirk‐Jan Reijngoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk‐Jan Reijngoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk‐Jan Reijngoud more than expected).

Fields of papers citing papers by Dirk‐Jan Reijngoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk‐Jan Reijngoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk‐Jan Reijngoud. The network helps show where Dirk‐Jan Reijngoud may publish in the future.

Co-authorship network of co-authors of Dirk‐Jan Reijngoud

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk‐Jan Reijngoud. A scholar is included among the top collaborators of Dirk‐Jan Reijngoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk‐Jan Reijngoud. Dirk‐Jan Reijngoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ríos-Morales, Melany, Madelon J. Logtenberg, Shohreh Keshtkar, et al.. (2024). Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine. Journal of Agricultural and Food Chemistry. 72(38). 21152–21165. 4 indexed citations
2.
Ríos-Morales, Melany, Marcel A. Vieira‐Lara, Miriam Langelaar‐Makkinje, et al.. (2022). Butyrate oxidation attenuates the butyrate-induced improvement of insulin sensitivity in myotubes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(11). 166476–166476. 14 indexed citations
3.
Derks, Terry G. J., et al.. (2014). From genome to phenome—Simple inborn errors of metabolism as complex traits. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(10). 2021–2029. 7 indexed citations
4.
Besten, Gijs den, Karen van Eunen, Albert K. Groen, et al.. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research. 54(9). 2325–2340. 3650 indexed citations breakdown →
5.
Smit, Gerrit, et al.. (2013). In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes. Orphanet Journal of Rare Diseases. 8(1). 43–43. 18 indexed citations
6.
Groot, Martijn J. de, Marieke Hoeksma, Dirk‐Jan Reijngoud, et al.. (2013). Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet Journal of Rare Diseases. 8(1). 133–133. 35 indexed citations
7.
Gerding, Albert, et al.. (2012). Competition between fatty-acid beta-oxidation enzymes makes the pathway vulnerable to substrate overload. FEBS Journal. 279. 520–521. 1 indexed citations
8.
Smit, Gerrit, Maaike de Vries, Johannis B.C. de Klerk, et al.. (2012). Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study. Orphanet Journal of Rare Diseases. 7(1). 30–30. 24 indexed citations
9.
Rijn, Margreet van, et al.. (2011). Diurnal variations in blood phenylalanine of PKU infants under different feeding regimes. Molecular Genetics and Metabolism. 104. S68–S72. 6 indexed citations
10.
Rijn, Margreet van, et al.. (2011). Adult Patients with Well-Controlled Phenylketonuria Tolerate Incidental Additional Intake of Phenylalanine. Annals of Nutrition and Metabolism. 58(2). 94–100. 19 indexed citations
11.
Herrema, Hilde, Maxi Meissner, Theo H. van Dijk, et al.. (2009). Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor– and Liver X Receptorα–Controlled Metabolic Pathways in Mice. Hepatology. 51(3). 806–816. 81 indexed citations
12.
Dijk, Theo H. van, Aldo Grefhorst, Maaike H. Oosterveer, et al.. (2009). An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption in Fxr–/– Mice. Journal of Biological Chemistry. 284(16). 10315–10323. 54 indexed citations
13.
Teune, Laura K., Natasha M. Maurits, Arend F. Bos, et al.. (2007). Pyridoxine induces non-specific EEG alterations in infants with therapy resistant seizures. Seizure. 16(5). 459–464. 3 indexed citations
14.
Korsheninnikova, Elena, Gerard C.M. van der Zon, Peter J. Voshol, et al.. (2006). Sustained activation of the mTOR nutrient sensing pathway associates with hepatic insulin resistance but not with steatosis per se in mice. Diabetologia. 49. 393–394. 1 indexed citations
15.
Reijngoud, Dirk‐Jan, et al.. (2005). RESPIRATORY INSUFFICIENCY AS FIRST PRESENTATION OF MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY (MADD). Journal of Inherited Metabolic Disease. 28. 115–115.
16.
Rijn, M. van, et al.. (2005). NORMAL PROTEIN METABOLISM IN PATIENTS WITH PHENYLKETONURIA. Data Archiving and Networked Services (DANS). 2 indexed citations
17.
Velden, Monique G. de Sain-van der, George A. Kaysen, Frans Stellaard, et al.. (1998). Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney International. 53(4). 994–1001. 2 indexed citations
18.
Velden, Monique G. de Sain-van der, George A. Kaysen, Frans Stellaard, et al.. (1998). Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney International. 53(4). 994–1001. 67 indexed citations
19.
Velden, Monique G.M. de Sain–van der, Ton J. Rabelink, Dirk‐Jan Reijngoud, et al.. (1998). Plasma α2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney International. 54(2). 530–535. 47 indexed citations
20.
Niezen‐Koning, Klary E., Ronald J. A. Wanders, Jos P.N. Ruiter, et al.. (1997). Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature. European Journal of Pediatrics. 156(11). 870–873. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026